These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 9753266)

  • 21. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
    Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
    Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
    J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity.
    Kim TI; Lee YC; Lee KH; Han JH; Chon CY; Moon YM; Kang JK; Park IS
    Infect Immun; 2001 Aug; 69(8):5056-63. PubMed ID: 11447186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of COX-2 inhibition on the formation and healing of gastric ulcers induced by indomethacin in the rat.
    Godessart N; Salcedo C; Fernández AG; Palacios JM
    Adv Exp Med Biol; 1999; 469():157-63. PubMed ID: 10667325
    [No Abstract]   [Full Text] [Related]  

  • 27. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats.
    Ochi T; Yamane-Sugiyama A; Ohkubo Y; Sakane K; Tanaka H
    Jpn J Pharmacol; 2001 Feb; 85(2):175-82. PubMed ID: 11286400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs.
    Yamamoto H; Tanaka A; Kunikata T; Hirata T; Kato S; Takeuchi K
    J Physiol Paris; 1999 Nov; 93(5):405-12. PubMed ID: 10674917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healing of duodenal ulcers is not impaired by indomethacin or rofecoxib, the selective COX-2 inhibitor, in rats.
    Araki H; Komoike Y; Matsumoto M; Tanaka A; Takeuchi K
    Digestion; 2002; 66(3):145-53. PubMed ID: 12481160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
    Berenguer B; Alarcón de la Lastra C; Moreno FJ; Martín MJ
    Eur J Pharmacol; 2002 May; 442(1-2):125-35. PubMed ID: 12020690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A; Hase S; Miyazawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):754-61. PubMed ID: 11861778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats.
    Nakatsugi S; Terada N; Yoshimura T; Horie Y; Furukawa M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):395-402. PubMed ID: 9014217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
    Takeuchi K; Tanaka A; Hayashi Y; Kubo Y
    Dig Dis Sci; 2004 Feb; 49(2):180-7. PubMed ID: 15104355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NSAID inhibition of RGM1 gastric monolayer wound re-epithelialization: comparison of selective Cox-2 versus non-selective Cox inhibitors.
    Giap AQ; Tarnawski A; Hoa NT; Akotia V; Ma TY
    Life Sci; 2002 May; 70(25):3029-37. PubMed ID: 12138016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A selective cyclo-oxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury.
    Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Sugimachi K
    J Gastroenterol Hepatol; 1999 Jul; 14(7):642-51. PubMed ID: 10440208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The roles of nitric oxide and prostaglandins in alterations of ulcerogenic and healing responses in adjuvant-induced arthritic rat stomachs.
    Kato S; Tanaka A; Kunikata T; Mizoguchi H; Takeuchi K
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():18-25. PubMed ID: 10807399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.